SMAD3 and cancer: Hypoxia-induced activation of the SMAD3 pathway through increased SMAD3 bioavailability and recruitment to the adapter protein SARA induced tumor progression and cancer cell invasion, events associated with the expression of SMAD3 gene targets ITGB2 and VIM.